Table 1.
Baseline characteristics of the population at the enrolment (N: 229 patients).
Table 2.
Baseline characteristics in not infected and infected patients.
Table 3.
Comparison of baseline characteristics of infected patients with MDROs and infected patients without MDROs.
Fig 1.
Incidence rates for total infections (MDSOs and MDROs)/person/year and for MDROs infections/person/year.
Table 4.
Multivariate analysis with infections (both MDROs and multi-drugs sensible organisms) as dependent variable.
Fig 2.
Survival cumulative Hazards between patients with and without infections.
Yellow line: not infected patients, blue line: infected patients.
Fig 3.
Survival cumulative Hazards between patients with MDROs infections and not infected.
Yellow line: not infected patients, blue line: MDROs-infected patients.